Anti-COVID19 hyperacute serum in the treatment of viral disease

  • Funded by National Research, Development and Innovation Office (NRDI)
  • Total publications:1 publications

Grant number: 2020-2.1.1-ED-2020-00005

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $256,000
  • Funder

    National Research, Development and Innovation Office (NRDI)
  • Principal Investigator

    N/A

  • Research Location

    Hungary
  • Lead Research Institution

    OrthoSera Kft.
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Professional Athletes Maintain High TNF-Alpha or IFN-Gamma Related Inflammatory Status after Recovering from COVID-19 Infection without Developing a Neutralizing Antibody Response.